ArticleArchives of rheumatology2025
Temporal Trend and Health Inequality in the Burden of Autoimmune Diseases Among Older Adolescents and Young Adults Aged 15-29 Years.
Article in Archives of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: Autoimmune diseases (ADs) are a group of disorders characterized by the dysfunction of the immune system, leading to selfdirected attacks on organs or tissues. The global burden of ADs in older adolescents and young adults is still lacking and requires updates.This study described the global, regional, and country-specific disease burden and temporal trends of ADs in older adolescents and young adults (aged 15-29 years) from 1990 to 2019. Materials and Methods: Data from the 2019 Global Burden of Disease, Injury, and Risk Factors study were utilized to report age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (ASDR) rates of ADs at global, regional, and national levels. The average annual percent change was determined by Joinpoint regression analysis. Results: In 2019, the burden of alopecia areata (AA) and rheumatic heart disease (RHD) in older adolescents and young adults was particularly notable. Specifically, the ASIR for AA was 493.84 per 100 000 (95% uncertainty interval (UI): 444.13, 544.49), while the ASPR, ASMR, and ASDR for RHD were 771.43 per 100 000 (95% UI: 529.38, 1074.04), 1.08 per 100 000 (95% UI: 0.94, 1.23), and 108.36 per 100 000 (95% UI: 88.63, 133.67), respectively. From 1990 to 2019, the heavy disease burden of ADs was more pronounced in the European region and region of the Americas, where Italy and El Salvador were particularly affected. Although the burden of ADs was generally more severe in females than in males across most regions, males consistently had higher ASIR (10.19 per 100 000; 95% UI: 4.68, 18.22), ASPR (249.77 per 100 000; 95% UI: 186.89, 325.98), ASMR (0.53 per 100 000; 95% UI: 0.47, 0.60), and ASDR (47.59 per 100 000; 95% UI: 40.97, 56.34) for type 1 diabetes mellitus (T1DM) compared to females. Conclusion: Globally, there is an increasing burden of AA, T1DM, and RHD in older adolescents and young adults. The American and European regions and females endure a severe burden of ADs. Healthcare providers should be aware of the heavy burden of ADs and develop age-appropriate prevention, diagnosis, and intervention strategies to achieve health equity.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.